CASE REPORT article
Front. Oncol.
Sec. Cancer Imaging and Image-directed Interventions
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1423520
Case report: peritoneal and small bowel metastasis from lung adenocarcinoma with EGFR L858R mutation
Provisionally accepted
- Huadu District People’s Hospital, Southern Medical University, Guangzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Abstract Recently, cases of lung cancer metastasizing to atypical sites, such as the small intestine and colon, have been reported; however, peritoneal metastasis remains uncommon. Herein, we present the case of a patient with stage IV lung adenocarcinoma with an EGFR L858R mutation, who developed peritoneal metastasis involving the small intestine, leading to intestinal obstruction and death following osimertinib resistance.
Keywords: EGFR, Lung Adenocarcinoma, Peritoneal, Small bowel metastasis, Cancer
Received: 30 Apr 2024; Accepted: 04 Mar 2025.
Copyright: © 2025 Tan, Huang, Yan and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Ying Liu, Huadu District People’s Hospital, Southern Medical University, Guangzhou, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.